Sloning BioTechnology GmbH Closes Growth Financing Round Led by LBBW Venture

PUCHHEIM, Germany--(BUSINESS WIRE)--Sloning BioTechnology GmbH, the worldwide leading supplier of combinatorial gene libraries, received additional investments from all of its institutional shareholders: HBM BioVentures, LBBW Venture, DEWB and KfW to finance the company’s ongoing commercial growth strategy in the field of protein engineering.

MORE ON THIS TOPIC